D81.9
Combined immunodeficiency, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Severe combined immunodeficiency disorder [SCID] NOS
Medical Intelligence & Overview
Combined immunodeficiency, unspecified (ICD-10 Code D81.9), refers to a group of rare conditions where the immune system is severely weakened. This impairment makes individuals more vulnerable to infections that a healthy immune system could normally fight off. The condition is sometimes related to severe combined immunodeficiency disorder (SCID), but in this case, the precise type or cause has not been specified. People with this condition often require ongoing medical care to manage their immune system dysfunction and prevent serious health complications.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting the development and function of T cells and B cells, which are critical components of the immune system. Inherited conditions passed down through families that affect immune system development. Unknown causes in some cases, where specific genetic or environmental factors are not identified.
Key Symptoms: Frequent, severe infections that tend to recur and are difficult to treat. Infections caused by bacteria, viruses, fungi, and parasites that healthy individuals usually fight off. Persistent diarrhea and failure to thrive in infants. Recurrent pneumonia or lung infections. Skin infections or rashes that do not improve with typical treatments. Possible delay in developmental milestones if the immune deficiency is present from birth.
Diagnostic & Treatment
Diagnosis Path: Diagnosis often involves a series of tests to evaluate immune system function, including blood tests to measure levels of immune cells such as T cells, B cells, and natural killer (NK) cells. Additionally, genetic testing may be performed to identify specific mutations. A clinical history of recurrent infections and physical examinations are also critical components. In some cases, specialized tests, like immunoglobulin levels and lymphocyte proliferation assays, are used to confirm the diagnosis.
Treatment Protocols: Immunoglobulin replacement therapy to provide necessary antibodies that the body cannot produce adequately. Prophylactic antibiotics or antifungal medications to prevent infections. Gene therapy or hematopoietic stem cell transplantation (bone marrow transplant) in suitable candidates to potentially cure the condition. Supportive care, including prompt treatment of infections and supportive therapies to improve quality of life. Regular monitoring by healthcare professionals specialized in immunology.
Clinical Advice & FAQs
Billing Guidance
Is D81.9 a billable ICD-10 code?
Yes, D81.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D81.9?
Clinical documentation must specify the nature of Combined immunodeficiency, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
